Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 46 of the 47 references it cites were found in a registry or an index; 29 of the 47 sources its claims cite were checked for support.

Salt-wasting congenital adrenal hyperplasia phenotype as a result of the TNXA/TNXB chimera 1 (CAH-X CH-1) and the pathogenic IVS2-13A/C > G in CYP21A2 gene

Open access

Abstract

BACKGROUND: Genetic diversity of mutations in the CYP21A2 gene is the main cause of the monogenic congenital adrenal hyperplasia (CAH) disorder. On chromosome 6p21.3, the CYP21A2 gene is partially overlapped by the TNXB gene, the two residing in tandem with their highly homologous corresponding pseudogenes (CYP21A1P and TNXA), which leads to recurrent homologous recombination. METHODS AND RESULTS: In the present study, the genetic status of an ethnic Greek-Cypriot family, with a female neonate that was originally classified as male and manifested the salt-wasting (SW) form, is presented. Genetic defects in the CYP21A2 and TNXB genes were investigated by Sanger sequencing multiplex ligation-dependent probe amplification (MLPA) and a real-time PCR assay. The neonate carried in compound heterozygosity the TNXA/TNXB chimeric gene complex (termed CAH-X CH-1) that results in a contiguous CYP21A2 and TNXB deletion and in her second allele the pathogenic IVS2-13A/C > G (c.655A/C > G) in CYP21A2. CONCLUSIONS: The classic SW-CAH due to 21-hydroxylase (21-OH) deficiency may result from various complex etiological mechanisms and, as such, can involve the formation of monoallelic TNXA/TNXB chimeras found in trans with other CYP21A2 pathogenic variants. This is a rare case of CAH due to 21-hydroxylase deficiency, which elucidates the role of the complex RCCX CNV structure in the development of the disease. Identification of the correct CAH genotypes for a given phenotype is of considerable value in assisting clinicians in prenatal diagnosis, appropriate treatment, and genetic counseling.

Overview

CoChat Summary

## TL;DR

This paper reports a rare salt-wasting classic congenital adrenal hyperplasia (SW-CAH) case in a Greek-Cypriot neonate caused by compound heterozygosity for a TNXA/TNXB chimera (CAH-X CH-1) and the pathogenic CYP21A2 variant IVS2-13A/C > G. The case illustrates how complex RCCX copy-number variation can shape CAH phenotype and why detailed genotyping matters for diagnosis, treatment, and counseling.

## Key findings

  • The neonate had SW-CAH with severe virilization (Prader 5) and biochemical salt-wasting findings, including hyponatremia, hyperkalemia, high plasma renin activity, 17-OHP > 75.7 nmol/L, and high ACTH.
  • Genetic testing by Sanger sequencing, MLPA, and real-time PCR showed the infant was compound heterozygous for CAH-X CH-1 and IVS2-13A/C > G (c.655A/C > G) in CYP21A2.
  • The mother carried IVS2-13A/C > G in heterozygosity, and the father carried the TNXA/TNXB chimera (CAH-X CH-1) in heterozygosity.
  • The authors note that CAH-X syndrome is estimated in ~7–9% of CAH patients, and ~10% of classic SW-CAH patients harboring a TNXB/CYP21A2 genotype may show the extended CAH-X phenotype.

## Methods

  • Design: Single-patient family case study with molecular characterization of a classic SW-CAH presentation.
  • Sample/data: A female neonate from a non-consanguineous Greek-Cypriot family, plus both parents; clinical history and biochemical findings were used alongside DNA testing.
  • Analysis: Sanger sequencing, MLPA, and a real-time PCR CAH Real Fast CNV assay were used to investigate CYP21A2 and TNXB defects and confirm the large deletion/chimeric allele.

## Limitations

  • The paper states no formal study limitations; this is a single rare case report, so the findings are inherently not generalizable beyond this family.
  • The text makes evident that no long-term follow-up or broader phenotype assessment (for example, later CAH-X/EDS manifestations) is reported here.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1007/s42000-022-00410-w

Cites

46 of 46 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Fig. 1 A Pedigree of the investigated family with congenital adrenal hyperplasia. Gray shading indicates the presence of the TNXA/TNXB CH-1 chimeric allele, and hatched lines indicate the presence of the IVS2-13A/C > G mutation. B Sanger sequencing electropherograms indicating the severe IVS2-13A/C > G mutation identified in heterozygosity in the mother and in hemizygosity in the neonate female patient. The position of the IVS2-13A/C > G mutation is shown by red arrows. C MLPA electropherograms (left) and ratio charts (right) showing the CYP21A2 gene deletion extending to exon 35 of TNXB. The father and the neonate patient carried in heterozygosity the TNXA/TNXB CH-1 chimeric gene. Red arrows indicate the reduction of specific sites located on the CYP21A2 and TNXB genes
Fig. 1 A Pedigree of the investigated family with congenital adrenal hyperplasia. Gray shading indicates the presence of the TNXA/TNXB CH-1 chimeric allele, and hatched lines indicate the presence of the IVS2-13A/C > G mutation. B Sanger sequencing electropherograms indicating the severe IVS2-13A/C > G mutation identified in heterozygosity in the mother and in hemizygosity in the neonate female patient. The position of the IVS2-13A/C > G mutation is shown by red arrows. C MLPA electropherograms (left) and ratio charts (right) showing the CYP21A2 gene deletion extending to exon 35 of TNXB. The father and the neonate patient carried in heterozygosity the TNXA/TNXB CH-1 chimeric gene. Red arrows indicate the reduction of specific sites located on the CYP21A2 and TNXB genesCC BY · PubMed Central
Fig. 2 Schematic representation of the RCCX locus on chromosome 6p21.3 in which the TNXA and TNXB genes undergo unequal crossover resulting in a TNXA/TNXB CH-1 chimera
Fig. 2 Schematic representation of the RCCX locus on chromosome 6p21.3 in which the TNXA and TNXB genes undergo unequal crossover resulting in a TNXA/TNXB CH-1 chimeraCC BY · PubMed Central
Fig. 3 CAH Real Fast CNV Assay (real-time PCR, Vienna Lab) showing the large CYP21A2 deletion that was detected both in the patient and in the paternal samples and which confirms the monoallelic TNXA/TNXB CH-1 chimera that was identified both in the father and in the neonate
Fig. 3 CAH Real Fast CNV Assay (real-time PCR, Vienna Lab) showing the large CYP21A2 deletion that was detected both in the patient and in the paternal samples and which confirms the monoallelic TNXA/TNXB CH-1 chimera that was identified both in the father and in the neonateCC BY · PubMed Central

Verification

Claims the paper makes

17 Valid · 3 Not valid · 2 Not checked · 13 Own results and interpretations

12 more claims · 3 with their cited sources checked

Create a free account to see all 35 claims and every source verdict.

See all claims — free account
  • Probably not a substantial claim. 11
  • It may state two separate claims as one. 9

Create a free account to see these claims.

Citations

Cites

Show all 47 references

Cited by

See all 4

Metadata

Authors
Fanis, P., Skordis, N., Phylactou, L. A., & Neocleous, V.
Affiliations
  • Cyprus Institute of Neurology and Genetics (CY)
  • University of Nicosia (CY)
Corresponding author
Phylactou, Leonidas A.
Venue
HORMONES
Published
2022-10-20
Volume
22
Issue
1
Pages
71-77
ISSN
  • 1109-3099 (ISSN-L)
  • 2520-8721
OpenAlex
W4306912920
Cited by
4
References
47
Citations by year
2024: 1 · 2023: 3
FWCI
0.33
Type
journal article
Language
en
Open access
Licence
Locations
  • HORMONES (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
A.G. Leventis Foundation
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
Keywords
salt-wasting congenital adrenal hyperplasia, CYP21A2, 21-hydroxylase deficiency, compound heterozygosity, homologous recombination, contiguous gene deletion, pseudogenes, genetic counseling, prenatal diagnosis
MeSH terms
Adrenal Hyperplasia, Congenital, Female, Humans, Male, Mutation, Phenotype, Steroid 21-Hydroxylase, Tenascin

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Salt-wasting congenital adrenal hyperplasia phenotype as a result of the TNXA/TNXB chimera 1 (CAH-X CH-1) and the pathogenic IVS2-13A/C > G in CYP21A2 gene. https://app.cochat.ai/papers/10.1007/s42000-022-00410-w
The paper
Fanis, P., Skordis, N., Phylactou, L. A., & Neocleous, V. (2023). Salt-wasting congenital adrenal hyperplasia phenotype as a result of the TNXA/TNXB chimera 1 (CAH-X CH-1) and the pathogenic IVS2-13A/C > G in CYP21A2 gene. HORMONES. https://doi.org/10.1007/s42000-022-00410-w

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.